In a study on the molecular mechanism of thymine-DNA glycosylase (TDG) treatment for CRC, Miao et al. (2022) found that TDG could bind to and promote the ubiquitination and degradation of DNMT3A, by inhibiting CRC migration and invasion. This evidence concerns the gene TDG and colorectal carcinoma.